프로티나

468530KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

46,000KRWMarket close of 10/21 (Wed)

Up +7.23%+3,100KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)42,750KRWDown -7.07%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
44,150
High
47,500
Low
43,050
Day range
Day range low 43,050 high 47,500, open 44,150, close 46,000, previous close 42,900
Volume
24×10K shares
11.0B KRW 1.47× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 15,860 to 111,800 won, 31% up from the low

31% of the way up from the lowest close in 1 year (252 sessions) · -58.9% from the high

Usual range

Nothing unusual in the 5 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Daily moveusual range+7.23%+7.23%, 1.0× the usual (20-session average ±7.04%)
    That day +7.23% · usual ±7.04% · large-move threshold ±14.1%
  • Trading valueusual range1.5×11.0B KRW, 1.5× the 20-session average
    1.47× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+2.6B KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
알지노믹스Close over the last 20 sessions -8.9%Up +7.26%10.5B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.